A COMPARISON OF ANTI-TYPE 2 DIABETES MELLITUS DRUGS IN CANADA, THE UNITED STATES AND THE UNITED KINGDOM

Simple item page
dc.contributor.advisorTewodros, Eguale, MD, PhD (Research Advisor) Associate Professor of Pharmaceutical Economics and Policy
dc.contributor.authorMOHAMMED ABDULLAH ALQAHTANI
dc.date2016
dc.date.accessioned2022-06-02T10:28:55Z
dc.date.available2022-06-02T10:28:55Z
dc.degree.departmentPHARMACY
dc.identifier.other29793
dc.identifier.urihttps://drepo.sdl.edu.sa/handle/20.500.14154/62871
dc.publisherSaudi Digital Library
dc.titleA COMPARISON OF ANTI-TYPE 2 DIABETES MELLITUS DRUGS IN CANADA, THE UNITED STATES AND THE UNITED KINGDOM
dc.typeThesis
sdl.thesis.levelMaster
sdl.thesis.sourceSACM - United States of America

Files

Collections

SACM - United States of America

Copyright owned by the Saudi Digital Library (SDL) © 2025